Better long-term outcomes with early intensive MS therapy: study

Do current escalation approaches miss a therapeutic opportunity?

Multiple sclerosis (MS) patients who receive high-efficacy therapy early fare better long-term than those on an escalation-based approach to treatment, according to new research.

# Tags